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analysis
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University Eye Hospital, Freiburg, Germany
Purpose: Cytokine patterns determined in the aqueous humor before penetrating keratoplasty (PK) may enable us to
predict immune reactions (IR). We therefore analyzed 6 cytokines in the aqueous humor of patients before PK. By
prospective clinical follow-up, we tested whether patients who developed an IR would present different preoperative
cytokine patterns compared to patients without IR.
Methods: We analyzed 18 samples of aqueous humor from 18 patients undergoing PK. The following cytokines were
analyzed by cytometric bead array: interleukin 2 (IL-2), interleukin 4 (IL-4), interleukin 5 (IL-5), interleukin 10 (IL-10),
tumor-necrosis-factor α (TNF-α), and interferon γ (INF-γ). Seven patients presented with signs of IR during follow up.
We performed Cox proportional hazards analysis to determine significant predictors for IR. We iteratively eliminated all
co-variates with p values over 0.1 from the survival model (backward selection).
Results: Our final Cox model included the hazardous factors IL-4 (p=0.043) and INF-γ (p=0.059), protective factors IL-2
(p=0.081), IL-5 (p=0.028), and age at time of surgery (p=0.029). We performed a linear discriminant analysis based on
these  coefficients.  The  resulting  function  was:  (−9.979*IL5)  +  (9.262*IL4)  +  (−3.928*IL2)  +  (1.709*IFN-γ)  +
(−0.183*age). A median of −4.97 separated patients with and without IR with no classification error.
Conclusions: We demonstrate that cytokine levels in the aqueous humor can be predictive for IR. Our method allowed
an almost 100% separation between patients with and without IR. This finding has the potential to improve the aftercare
of PK fundamentally. However, our results need to be confirmed in a larger prospective cohort.
Corneal graft rejection remains the most important reason
for  graft  failure  [1].  Despite  intense  research,  the  precise
mechanisms  leading  to  graft  rejection  are  not  fully
understood. Regarding the immunosuppressive climate in the
anterior  chamber,  the  contents  of  specific  cytokines  may
correlate with the development of immune reactions or long-
term clear graft survival. We have observed that active [2] but
not total [3] transforming growth factor beta 2 (TGF-β2) is
reduced during endothelial immune reactions. Moreover, we
found that active TGF-β2 is increased in the aqueous humor
of keratoconus patients before penetrating keratoplasty (PK),
which might be one reason for their excellent graft prognosis
[4]. Regarding the occurrence of immune reactions T helper
cell type 1 (Th1)-type cytokines such as interleukin-2 (IL-2),
interferon gamma (INF-γ), or tumor necrosis factor alpha
(TNF-α)  are  more  likely  to  be  associated  with  allograft
rejection than Th2-type cytokines such as interleukin-4 (IL-4),
interleukin-5 (IL-5), interleukin-6 (IL-6), or interleukin-10
(IL-10) [5]. However, the exact effects of most cytokines in
the aqueous humor regarding the development, maintenance
and resolution of the endothelial immune reaction are not fully
understood.
We therefore analyzed 6 different cytokines (IL-2, IL-4,
IL-5, IL-10, INF-γ, and TNF-α) in the aqueous humor of
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patients  before  penetrating  keratoplasty,  following  them
prospectively. We compared the cytokine profiles of patients
at the time of transplant in whom signs of endothelial rejection
were or were not later found during the follow-up period.
METHODS
Patients: All patients underwent penetrating keratoplasty for
the first time at the University Eye Hospital Freiburg. None
of the patients received topical steroids preoperatively. All
invasive  procedures  were  performed  in  adherence  to  the
Declaration  of  Helsinki  for  research  involving  human
subjects.  Research  was  approved  by  our  local  ethics
committee. After obtaining written informed consent, samples
were drawn from a consecutive series of patients undergoing
penetrating keratoplasty. Detailed clinical information on all
study patients is summarized in Table 1.
All  keratoplasties  were  performed  using  mechanical
trephines with a diameter of 8 mm. To fix the grafts, we used
a  double  running  cross-stitch  suture  with  10.0  nylon  [6].
Gentamycine ointment was administered following surgery at
least until the graft had been covered by a complete epithelial
layer. Prednisolone-21-acetate 1% eye drops were then given
5 times daily and tapered during the first 5 postoperative
months.  For  all  patients  included  in  the  study  systemic
corticosteroids  were  administered  for  only  3  weeks
postoperatively  to  protect  the  graft  during  the  first  post
surgical period. Oral acetazolamide was administered at a
daily dose of 2×250 mg for 5 days postoperatively. High-risk
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1016cases were defined by an increased risk for immune reactions
as  described  elsewhere  [7].  These  patients’  postoperative
treatment additionally included mycophenolate mofetil for 6
months postoperatively (see Table 1).
All grafts were preserved in organ culture according to
the guidelines of the European Eye Bank Association. There
were no significant differences for donor age, postmortem
time, storage time and preoperative endothelial cell density
between patients with and without graft rejection (data not
shown).
Anterior chamber puncture was performed as described
elsewhere  [8].  Briefly,  a  paracentesis  lancet  was  used  to
penetrate the cornea in an avascular peripheral area over a
length of 1 mm. Contact with limbal or peripheral corneal
vessels was completely avoided. Aqueous humor (0.05-0.1
ml) was drawn into conventional tuberculin syringes without
coming into contact with intraocular structures. All samples
were  rapidly  frozen  to  −20  °C  and  kept  at  −80  °C  until
determination  using  cytometric  bead  array.  To  receive  a
representative and comparable sample size of patients with
and without immune reaction some of the samples were drawn
at the time of surgery and frozen afterwards. When the patients
later during follow up presented with an endothelial immune
reaction, the samples were thawed and the cytokine analysis
was performed. By this we artificially increased the number
of patients with immune reactions, so that in the normal risk
group the ratio of patients with immune reaction was higher
than in the high risk group. Therefore, the number of patients
with immune reactions in the normal risk group is higher than
it would be expected.
Only endothelial immune reactions were included as the
primary endpoint in this study and were diagnosed at the
slitlamp when endothelial immune precipitates accompanied
by stromal edema were visible.
The cytokine levels in each sample were measured using
a  Cytometric  Bead  Array  (CBA  kit;  RD  Bioscience,  San
Diego,  CA)  according  to  the  manufacturer's  manual  and
described  elsewhere  [9].  Data  were  acquired  by  flow
cytometry (FACS Clibur; BD Bioscience). For our analyses,
we used the Th-1/Th-2 Kit (RD Bioscience, San Diego, CA)
for determining IL-2, IL-4, IL-5, IL-10, TNF-α, and INF-γ.
All values were calculated with regards to the negative control
in each assay. If the fluorescent signal of a sample was equal
to  or  below  the  fluorescence  of  the  negative  control,  the
cytokine level was set as 0.0 pg/ml.
All statistical computations were performed using the R-
Software  system  [10].  To  achieve  better  comparability
between the different cytokines we normalized all data by
dividing each cytokine value by its respective maximum in
the whole cohort before analysis, so that all cytokine values
TABLE 1. GRAFT AND PATIENT DATA OF ALL STUDY PATIENTS.
Patient number Patient age
(years)
Gender Indication Risk profile Postoperative
treatment
Follow up
(days)
IR
patient 1 63 f FT N S 1320 no
patient 2 80 f B N S 487 no
patient 3 21 m K N S 1084 no
patient 4 20 m K N S 594 no
patient 5 49 m HSV H M 639 no
patient 6 30 m K N S 261 yes
patient 7 88 f U H S 554 no
patient 8 79 f FT N S 219 yes
patient 9 80 f B N S 49 no
patient 10 47 f K N S 173 yes
patient 11 62 m U H M 519 no
patient 12 62 f F N S 538 no
patient 13 73 m HSVT H M 235 yes
patient 14 71 m F N S 342 yes
patient 15 84 f U H M 142 no
patient 16 41 m F N S 441 yes
patient 17 56 f F N S 730 no
patient 18 77 m F N S 213 yes
mean/% all 60.1 50%f na 72%N 78%S 474 na
mean/% without IR 60.4 64%f na 64%N 73%S 605 na
mean/% with IR 60.7 29%f na 86%N 86%S 269 na
PK=penetrating keratoplasty, ECD=endothelial cell density, IR=immune reaction. Gender: f=female, m=male. Indications:
B=bullous keratopathy, F=Fuchs’ endothelial dystrophy, K=keratoconus, U=acute corneal ulcer, HSV=herpes simplex virus
keratitis, T=triple procedure means combined surgery of penetrating keratoplasty with cataract extraction and posterior chamber
lens. Risk profile: n=normal risk, H=high risk (definition see section patients and methods). Postoperative treatment: S=standard
        as described in the methods section, M=mycophenolate mofetil for 6 months postoperatively. ND=not determined, na=not
        applicable. For patients with immune reactions the time of follow-up reflects the time point of the occurrence of an immune
        reaction.
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1017were  between  0  and  1.  We  performed  Cox  proportional
hazards analysis to determine the significant predictors for IR
during follow up. We entered age at time of surgery and the
normalized cytokine levels as co-variates into the model. We
iteratively eliminated all co-variates with p values higher than
0.1 from the survival model by backward selection. The final
model consisted of co-variates with p-values less than 0.1.
RESULTS
All  of  each  patient’s  cytokine  levels  and  the  respective
cytokine  scores  are  summarized  in  Table  2.  For  patients
without immune reaction levels of IL-2 (mean 1.7 versus 1.1
pg/ml) and IL-5 (mean 1.6 versus 0.9 pg/ml) as well as age
(mean 60.4 versus 59.7 years) were slightly higher and levels
of IL-4 (mean 1.8 versus 2.5 pg/ml), IL-10 (mean 1.2 versus
1.7 pg/ml), TNF-α (1.2 versus 1.7 pg/ml), and INF-γ (1.0
versus 1.1 pg/ml) were slightly lower than for patients with
immune reaction. In an earlier study [11] we determined the
same cytokines in control patients (n=26) receiving cataract
surgery only and found the following cytokine levels that
might  be  regarded  as  normal  values  (mean±standard
deviation): 1.64±0.91 pg/ml for IL-2, 1.86±1.13 pg/ml for
IL-4, 1.16±0.50 pg/ml for IL-5, 1.51±1.17 g/ml for IL-10,
1.23±0.76 pg/ml for TNF-α, and 0.62±1.18 pg/ml for INF-γ.
Regarding the absolute levels of each cytokine all values fell
within the range of the normal levels. However, we wanted to
test the hypothesis that it as a complex network of cytokines
that may be responsible for the individual rejection risk of the
patients. Therefore, we did not compare the cytokine levels
for  each  individual  cytokine  but  performed  the  Cox
proportional  hazards  analysis  to  find  a  significant
combination of parameters to differentiate between patients
with and without graft rejection.
When we tested whether the underlying disease leading
to penetrating keratoplasty also influenced the cytokine levels
in the aqueous humor of the different patients, we found a
statistically  significant  difference  between  the  indication
groups  (bulluos  keratopathy  (n=1),  Fuchs  endotehlial
dystrophy  (n=8),  keratoconus  (n=4),  herpetic  eye  disease
(n=2), corneal ulcers (n=3)) regarding age at time of surgery
(p=0,01, t-test), and the INF-γ level (p=0,003, t-test) in the
aqueous  humor.  Regarding  age  we  found  the  youngest
patients as expected in the keratoconus group. For INF-γ we
found highest levels in the eyes with herpetic eye disease.
However, these were only two cases where one developed an
immune reaction and the other did not.
Backward  selection  of  the  Cox  proportional  hazards
model is summarized in Figure 1. The third and final analysis
for predicting immune reactions revealed IL-2, IL-5, and age
to have significant graft protecting effects and IL-4 and INF-
γ to be significant hazardous factors.
TABLE 2. DETAILED INFORMATION ON CYTOKINE LEVELS.
  Cytokine      
Patient number Il-2 (pg/
ml)
IL-4 (pg/
ml)
IL-5 (pg/
ml)
IL-10 (pg/
ml)
INF-γ (pg/
ml)
TNF-α
(pg/ml)
Age
(years)
Cytokine
score*
IR
patient 1 1.2 1.4 1.1 1.2 0.0 0.0 63 −14.20 no
patient 2 1.5 1.7 1.3 2.5 0.0 1.4 80 −17.75 no
patient 3 1.9 1.9 1.2 1.7 0.0 1.5 21 −5.63 no
patient 4 1.8 0.0 1.5 1.5 1.8 1.2 20 −22.56 no
patient 5 1.5 0.0 1.2 1.2 2.8 1.4 49 −22.07 no
patient 7 2.3 3.7 2.3 4.3 4.7 0.0 88 −5.85 no
patient 9 1.2 1.4 0.0 1.6 1.2 0.0 80 −4.31 no
patient 11 1.2 1.8 2.0 4.0 0.0 0.0 62 −19.26 no
patient 12 2.2 3.1 1.2 1.5 0.0 1.6 62 −3.29 no
patient 15 0.0 1.7 3.9 2.3 2.2 1.2 84 −34.85 no
patient 17 4.0 3.2 1.7 2.1 0.0 2.4 56 −13.25 no
patient 6 0.0 3.6 2.9 0.0 0.0 4.5 30 −1.02 yes
patient 8 0.0 1.8 0.0 1.4 0.0 0.0 79 +2.25 yes
patient 10 0.0 1.2 0.0 0.0 0.0 0.0 47 +2.56 yes
patient 13 2.1 1.3 1.0 29.1 11.6 0.0 73 +0.24 yes
patient 14 3.8 5.7 2.2 3.9 0.0 3.0 71 +2.87 yes
patient 16 1.5 2.0 0.0 0.0 0.0 0.0 41 +5.06 yes
patient 18 0.0 1.7 0.0 0.0 0.0 0.0 77 +1.74 yes
mean/all 1.5 2.1 1.3 3.2 1.4 1.0 60.1 −8.30 na
median/all 1.5 1.75 1.2 1.6 0.0 0.6 62.5 −4.97  
mean/without IR 1.7 1.8 1.6 2.2 1.2 1.0 60.4 −14.82 na
median/without IR 1.5 1.7 1.3 1.7 0.0 1.2 62.2 −14.20  
mean/with IR 1.1 2.5 0.9 4.9 1.7 1.1 59.7 +2.0 na
median/with IR 0.0 1.8 0.0 0.0 0.0 0.0 71.3 +2.25  
        IR=immune reaction, na=not applicable. *The cytokine score has been calculated as described above including the regression
        coefficients from the Cox model.
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1018Regarding the model coefficients of each factor, IL-5
(model  coefficient:  −9.979,  hazard  ratio:  0.00046),  IL2
(model coefficient: −3.928, hazard ratio: 0.02) and age (model
coefficient: −0.183 per year, hazard ratio: 0.83) demonstrated
graft protecting effects in which IL-5 was the strongest factor
preventing immune reactions. On the other hand, IL-4 (model
coefficient: +9.262, hazard ratio: 10500) and INF-γ (model
coefficient:  +1.709,  hazard  ratio:  5.52)  revealed  effects
promoting the development of immune reactions, while IL-4’s
effect seemed to be stronger than that of INF-γ. We derived a
linear discriminant function (Equation 1) on the basis of the
coefficients from our final Cox model. We evaluated the score
from this function for differentiating between patients with
and  those  without  immune  reactions  in  a  second  step
[(Equation  1:  f(age,  IL5,  IL4,  IL2,  IFN)=(−9.979*IL5)  +
(9.262*IL4)  +  (−3.928*IL2)  +  (1.709*IFN-γ)  +
(−0.183*age)].
The cytokine score’s median in the whole study group
was  −4.97,  ranging  from:  −34.85  to  +5.06.  The  median
separated precisely the patients with and those without IR (see
Figure 1 and Figure 2A). There was no difference between
high and normal risk patients in the accuracy of classification
(Figure 2B), so that the use of mycophenolate mofetil did not
seem to bias the prediction value of the cytokine score.
DISCUSSION
This is the first study to correlate prospectively determined
cytokine levels in the aqueous humor of patients before PK to
the occurrence of endothelial immune reactions during the
postoperative course. Our statistical analyses revealed IL-2,
IL-4, IL-5, INF-γ, and age at time of surgery as most predictive
for immune reactions after PK. A simple linear discriminant
function based on these five factors resulted in an almost
100% accurate prediction.
However, the distinct cytokine profile may merely reflect
a breakdown of the ocular immune privilege in the high-risk
cases. If so, the clinical high-risk rating would be equally
predictive of immune reactions. Anyhow, the cytokine-score
retained predictive power in a Cox model that also included
the  high-  versus  low-risk  factor  (not  shown).  This  fact
emphasizes,  that  the  cytokine  profile  adds  predictive
information to the clinical rating into low- versus high-risk.
Although the absolute cytokine levels for all patients
reported in this study fell in the range of normal values that
were determined in an earlier study, it was the combination of
the  different  cytokine  levels  resulting  from  the  Cox
proportional hazards analysis that allowed a differentiation
between patients with and without rejection. This confirms the
hypothesis, that it is not a single cytokine that is responsible
for an intact immune privilege but a complex network of
various cytokines, so that immune reactions occur only if a
combination of parameters within this network are changed
simultaneously. The results of this study may therefore help
to understand which cytokines are more or less important in
Figure 1. Backward selection. As IL10 showed the least significant result (p=0.78) in the first analysis (A), it was excluded from the second
analysis. In the second analysis (B), TNF-α showed the least significant result (p=0.80), and was excluded from the third analysis (C). As the
level of significance for backward selection was chosen to be p<0.1, all factors included in analysis three (age, IL2, IL4, IL5, and IFN-γ) were
included in the final Kaplan–Meier survival analysis.
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1019Figure  2.  Occurence  of  immune
reactions separated by the median of the
cytokine score. Kaplan–Meier survival
analysis  showing  an  almost  100%
separation  accuracy  between  patients
with  and  without  immune  reactions
following PK by the median (−4.97) of
the calculated cytokine score (A, n=9 for
each  group).  This  differentiation  is
independent  from  the  patients’  risk
profile  (B,  definition  for  high  risk
situations  see  section  patients  and
methods).
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1020the context of endothelial immune reactions following corneal
transplantation.
Besides the 6 cytokines included in this study there are
many  more  cytokines  that  play  an  important  role  in  the
development, the maintenance and the resolution of immune
reactions (e.g., TGF-β2, IL-6, and α-MSH). However, due to
a limited sample volume we had to choose for one multiplex
bead array that included only the 6 cytokines reported in this
study.
Regarding the underlying disease leading to penetrating
keratoplasty that might also influence the cytokine levels in
the aqueous humor of the patients we found only statistically
significant differences for INF-γ which levels were highest in
patients with herpetic eye disease. As these were only two
cases of which one developed an immune reaction and the
other one did not, we think that there seems to be no significant
impact of the underlying disease on the overall cytokine score
used  to  differentiate  between  patients  with  and  without
immune reaction.
Graft protecting factors: The strongest graft protecting
factor in this study was IL-5, which stimulates B-cell growth,
and promotes the immature phenotype of antigen-presenting
cells. In an animal model of heart transplantation, IL-5 was
shown  to  potentially  prolong  allograft  survival  by  down-
regulating  IL-2  and  INF-γ  production  [12].  In  animal
experiments, antigen presenting cells from the central cornea
have been shown to migrate into the recipient’s lymphatics
giving rise to allorecognition and graft rejection [13]. As IL-5
is capable of promoting the immature phenotype of antigen
presenting cells in vitro, it may have graft protecting effects
in a clinical setting [14].
We  found  that  the  pro-inflammatory,  Th1-related
cytokine  IL-2  revealed  graft-protecting  rather  than  IR-
promoting effects in the aqueous humor of patients. As IL-2
is believed to be a barrier to tolerance, thus leading to immune
reactions [15], one would have anticipated that high levels of
IL-2 would increase the risk of immune reaction. However,
there is evidence that the survival times of IL-2 knockout mice
were  only  modestly  reduced.  Thus  IL-2  does  not  seem
necessary for allograft rejection [16] and the potential immune
reaction-inducing effect of IL-2 on T-cell proliferation may
be strong in vitro, but somehow paradoxical in vivo following
PK.
Factors increasing the risk for immune reactions: As
IL-4 is an anti-inflammatory cytokine secreted by activated
T-cells  it  was  surprising  that  it  was  the  strongest  factor
increasing the risk for an endothelial immune reaction. Graft
survival  has  been  successfully  prolonged  by  the  in  vivo
administration of IL-4 used in experimental models of solid
organ  transplantation  [17].  However,  IL-4  overexpression
was  not  sufficient  to  reduce  the  rejection  rate  of  corneal
allografts in a rat keratoplasty model using a gene therapy
approach [18]. As IL-4, unlike IL-5, fosters the differentiation
of antigen presenting cells in vitro [14], IL-4 might contribute
to graft rejections by inducing the differentiation of the graft’s
immature  myeloid  antigen-presenting  cells.  These
contradictory results reveal that IL-4 may exert both graft
protecting and immune reaction promoting effects in organ
transplantation [15].
As  INF-γ  is  a  strong  pro  inflammatory  cytokine  that
strengthens the Th-1 immune response, it is not surprising that
increased levels in the aqueous humor lead to a higher risk of
endothelial immune reactions following PK. We also found
that INF-γ is statistically significantly increased [11], whereas
TGF-β2, the counterpart of INF-γ, is statistically significantly
decreased in the aqueous humor of patients during an active
immune reaction [2].
Cytokines excluded from the final Cox model: TNF-α is
believed to be important in the initiation, maintenance, and
resolution of inflammation regarding inflammatory processes
leading  to  graft  rejection.  In  a  mouse  model  of  corneal
transplantation, Zhu et al. [19] showed that TNF-α expression
generally decreases during the first postoperative week and
remains  significantly  elevated  in  allogeneic  (but  not  in
syngeneic) grafts, implicating TNF-α as a mediator of the
alloimmune response in corneal transplantation. Perhaps this
explains why we did not find TNF-α to be prognostically
significant  regarding  the  occurrence  of  immune  reactions
when  determined  before  penetrating  keratoplasty.  Its
importance may lie in the maintenance, not the induction, of
immune reactions.
Although IL-10 is considered one of the most promising
immunosuppressive  cytokine  candidates,  exogenous  IL-10
administration did not prolong corneal graft survival in a rat
model  of  allotransplantation  [20].  Animals  injected
subconjunctivally with IL-10 even showed a tendency toward
earlier  rejection  when  compared  to  controls  [20].
Furthermore, we found statistically significantly increased
IL-10 levels in the aqueous humor of patients having an active
immune  reaction  compared  to  patients  without  immune
reactions or controls [11]. Gong et al. [21] demonstrated that
only systemic but not topical application of IL-10 gene vectors
prolonged corneal graft survival in a rat keratoplasty model.
They concluded that IL-10 modulates cytokine expression in
the draining lymph nodes, leading to graft-protecting effects.
We did not find that IL-10 is prognostically important in
predicting the occurrence of immune reactions in this study.
Therefore, as we know that cytokines can display paradoxical
effects [22], further investigation is required to determine the
role of IL-10 in corneal graft acceptance or rejection.
Genetic polymorphism of cytokines and growth factors:
Genetic cytokine and growth factor polymorphisms may be
responsible for the variation of cytokine levels in the aqueous
humor, since single nucleotide polymorphisms (SNPs) have
been shown to influence protein secretion in vitro and in vivo.
This  allows  to  categorize  individuals  as  high,  low  or
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1021intermediate producers of a given cytokine [23]. However, the
role of cytokine SNPs in affecting the immune response to the
allograft or drug therapy on corneal transplantation has not
been investigated. Therefore, including SNP analysis may
help  to  develop  a  more  complex  score  system  to  predict
immune reactions using a multi-variant approach based on the
genetic profile, on cytokine levels in the aqueous humor and
other relevant clinical risk factors.
The major limitation of this study is the fact that we have
not yet confirmed our findings in a second, larger, prospective,
and independent cohort. Nevertheless, we observed a cytokine
score that allows us to distinguish with almost 100% accuracy
between patients developing an endothelial immune reaction
following PK from those who do not. Therefore, our cytokine
score, including IL-2, IL-4, IL5, INF-γ, and age, may prove
to  be  a  helpful  tool  in  predicting  the  risk  of  endothelial
immune reaction at the time of surgery in the future. Patients
with a high cytokine score might then be treated as high-risk
patients,  and  thus  undergo  systemic  immunosuppressive
treatment  to  prevent  the  occurrence  of  immune  reactions.
However, our study results and the cytokine score need to be
verified in a larger study population and the importance of
those cytokine SNPs must also be examined before a modified
score may be incorporated into clinical practice.
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